Al's Comment:

 This combination makes sense and it is worth looking at this trial: https://clinicaltrials.gov/ct2/show/NCT04479241  

It is for patients with recurrent Glioblastoma.


Posted on: 02/02/2021

First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda

 


Click HERE to return to brain tumor news headlines.